S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.45 (-1.16%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,163.92 (-1.89%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,453.61 (-2.41%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.45 (-1.16%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,163.92 (-1.89%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,453.61 (-2.41%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.45 (-1.16%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,163.92 (-1.89%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,453.61 (-2.41%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.45 (-1.16%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,163.92 (-1.89%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,453.61 (-2.41%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

NASDAQ:EPZMEpizyme SEC Filings & 10K Form

$12.87
+0.03 (+0.23 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$12.50
Now: $12.87
$13.01
50-Day Range
$12.30
MA: $15.83
$20.46
52-Week Range
$9.73
Now: $12.87
$27.82
Volume712,110 shs
Average Volume1.11 million shs
Market Capitalization$1.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.02

SEC Filings

Epizyme (NASDAQ:EPZM) SEC Filings

DateFilerForm TypeView
08/04/2020
6:04 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2020
5:52 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
4:04 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
3:32 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
8:04 AM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
8:01 AM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:57 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:56 AM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:54 AM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
5:16 AM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4/A
06/30/2020
5:10 AM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4/A
06/30/2020
5:06 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4/A
06/26/2020
6:12 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:39 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:36 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:31 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
6:52 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2020
3:23 PM
Epizyme (Issuer)
Legorreta Pablo G. (Reporting)
RP Management, LLC (Reporting)
RPI Finance Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:19 PM
Epizyme (Issuer)
Giordano Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:17 PM
Allen Andrew R (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:17 PM
Epizyme (Issuer)
Richon Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:16 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:16 PM
Bogle Grant C. (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:16 PM
Epizyme (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:15 PM
Epizyme (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:15 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:15 PM
BATE KENNETH (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
5:59 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2020
5:42 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2020
1:05 PM
Epizyme (Filer)
Form DEFA14A
04/06/2020
8:46 PM
Epizyme (Filer)
Form PRE 14A
04/02/2020
6:02 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
6:00 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:11 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:01 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:01 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:00 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:00 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
5:52 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:41 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
5:09 AM
Epizyme (Subject)
RPI Finance Trust (Filed by)
Form SC 13D/A
02/14/2020
1:59 PM
Epizyme (Subject)
Palo Alto Investors LP (Filed by)
Form SC 13G/A
02/13/2020
5:47 PM
Epizyme (Issuer)
Legorreta Pablo G. (Reporting)
RP Management, LLC (Reporting)
RPI Finance Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
1:46 PM
Epizyme (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/10/2020
4:27 PM
Celgene European Investment Co LLC (Filed by)
Epizyme (Subject)
Form SC 13G/A
02/05/2020
5:10 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:03 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:02 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:01 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:00 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:19 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:18 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:17 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:16 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:15 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:31 AM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4/A
01/06/2020
5:38 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
3:15 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
11:41 AM
Epizyme (Subject)
RPI Finance Trust (Filed by)
Form SC 13D
11/08/2019
6:10 PM
Epizyme (Issuer)
Legorreta Pablo G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
6:07 PM
Epizyme (Issuer)
Legorreta Pablo G. (Reporting)
RP Management, LLC (Reporting)
RPI Finance Trust (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2019
6:11 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
3:07 PM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2019
5:38 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
3:54 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:15 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:46 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4/A
09/04/2019
7:35 PM
Bogle Grant C. (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
7:32 PM
Epizyme (Issuer)
Richon Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
7:32 PM
Bogle Grant C. (Reporting)
Epizyme (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2019
7:28 PM
Epizyme (Issuer)
Richon Victoria (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2019
3:16 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
5:06 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
5:05 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/19/2019
3:42 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
5:46 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
5:34 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
3:01 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
3:10 PM
Epizyme (Subject)
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Form SC 13D/A
07/02/2019
3:15 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
6:05 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:16 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:18 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:56 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:55 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:54 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:53 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:44 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:29 PM
Epizyme (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:28 PM
Epizyme (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:28 PM
BATE KENNETH (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:26 PM
Allen Andrew R (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:25 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:25 PM
Epizyme (Issuer)
Giordano Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:24 PM
Epizyme (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
3:13 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
5:46 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
5:39 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
5:17 AM
Epizyme (Filer)
Form DEFA14A
04/18/2019
5:15 AM
Epizyme (Filer)
Form DEF 14A
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.